Can short-term fasting up to 36 hours improve insulin sensitivity, and what are the safety considerations?

Short-Term Fasting (Up to 36 Hours) and Insulin Sensitivity

Short-term fasting up to 36 hours is NOT recommended for improving insulin sensitivity, particularly in individuals with diabetes or those on glucose-lowering medications, as established diabetes guidelines explicitly advise against meal skipping and prolonged fasting due to hypoglycemia risk, and the research evidence shows paradoxical worsening of glucose tolerance upon refeeding despite theoretical metabolic benefits.

Critical Safety Concerns Override Potential Benefits

The most authoritative guidance comes from diabetes nutrition therapy recommendations, which explicitly state "Do not skip meals" for individuals with diabetes 1. This recommendation is particularly emphatic for those on:

• Insulin therapy (any regimen): Meal skipping significantly increases hypoglycemia risk
• Insulin secretagogues (sulfonylureas, meglitinides): Fasting creates dangerous mismatch between medication action and glucose availability
• Any glucose-lowering medication: Requires consistent meal timing to prevent adverse events

The Paradox: Fasting-Induced Glucose Intolerance

The most critical finding from recent research directly contradicts the premise that short-term fasting improves insulin sensitivity:

48-hour fasting causes significant glucose intolerance that persists 24 hours after refeeding, with exaggerated glycemic responses to meals 2. This 2026 study demonstrated that:

• Glucose area under the curve increased substantially at 48 hours fasted compared to baseline
• Adding daily aerobic exercise during fasting did not prevent this glucose intolerance
• Females showed greater impairments in glucose metrics after refeeding than males
• The glucose intolerance remained elevated even 24 hours post-refeeding

Mechanistic Disconnect: Hepatic vs. Whole-Body Effects

A 2021 study examining 36-hour fasting revealed a critical mechanistic insight 3:

• Hepatic insulin action improved during prolonged fasting
• Whole-body insulin resistance increased simultaneously
• First-phase insulin secretion decreased slightly
• Paradoxically, serum insulin levels were higher during refeeding after prolonged fasting

This suggests that while the liver may become more insulin-sensitive, peripheral tissues (muscle, adipose) become more resistant—a net negative for metabolic health.

Limited Evidence in Healthy Populations

Even in healthy young adults without metabolic disease:

• A single 16-hour fast showed no enhancement of dietary protein incorporation into muscle or insulin sensitivity 4
• 36-hour fasting in healthy males showed improved hepatic but worsened whole-body insulin action 3
• Older studies from 1984 showed that 36-hour fasting required careful carbohydrate loading beforehand to prevent glucose intolerance 5

The Type 1 Diabetes Safety Study: Misleading Reassurance

While one 2021 study showed that people with type 1 diabetes could complete 36-hour fasting without severe hypoglycemia or ketoacidosis 6, this was:

• A highly controlled research setting with continuous glucose monitoring
• Conducted in metabolically stable individuals
• Not evidence that fasting improves insulin sensitivity
• Explicitly designed only to assess safety, not efficacy

This does not translate to a clinical recommendation for fasting.

Time-Restricted Eating: A Different Intervention

The Ramadan fasting literature 7 and time-restricted eating reviews 8, 9 describe time-restricted feeding (8-12 hour eating windows), which is fundamentally different from 36-hour fasting:

• TRE during Ramadan (typically 12-16 hour fasts) showed modest improvements in insulin sensitivity when combined with caloric restriction 7
• Benefits were primarily in metabolically unhealthy participants
• These findings do not extrapolate to 36-hour fasting protocols

Clinical Algorithm: When Fasting Is Absolutely Contraindicated

Do NOT recommend short-term fasting (>12 hours) if the patient has:

1. Type 1 diabetes (any insulin regimen)
2. Type 2 diabetes on insulin (any regimen)
3. Any sulfonylurea or meglitinide use
4. History of hypoglycemia
5. Cardiovascular disease (acute coronary syndrome, advanced heart failure) 7
6. Pregnancy or breastfeeding
7. Eating disorders or disordered eating patterns

What Actually Works for Insulin Sensitivity

Based on the evidence hierarchy prioritizing guidelines:

• Mediterranean diet: Most evidence-supported, 31% reduction in T2DM incidence 8
• Low glycemic index diets: Improve postprandial insulin dynamics 8
• DASH diet: Effective for insulin resistance, particularly in PCOS 8
• Moderate caloric restriction with regular meal timing: Safer and more sustainable than prolonged fasting 1

Common Pitfalls to Avoid

1. Confusing time-restricted eating (8-12 hour windows) with prolonged fasting (36 hours): These are distinct interventions with different risk profiles
2. Assuming metabolic flexibility during fasting equals improved insulin sensitivity: The refeeding glucose intolerance demonstrates this is false
3. Extrapolating Ramadan fasting data: Religious fasting occurs with community support, specific timing, and cultural adaptation—not comparable to isolated 36-hour fasts
4. Ignoring medication interactions: Even metformin requires meal timing considerations 1

Bottom Line for Clinical Practice

For improving insulin sensitivity, recommend evidence-based dietary patterns (Mediterranean, low-GI, DASH) with consistent meal timing rather than prolonged fasting. The guideline-level recommendation to avoid meal skipping in diabetes management 1, combined with research showing fasting-induced glucose intolerance 2 and paradoxical metabolic effects 3, makes 36-hour fasting an inappropriate intervention for insulin sensitivity improvement in real-world clinical practice.